Literature DB >> 8255683

Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by the instillation technique.

H Segerer1, W van Gelder, F W Angenent, L J van Woerkens, T Curstedt, M Obladen, B Lachmann.   

Abstract

Surfactant bolus instillation has been reported to cause changes in arterial blood pressure (BP) and cerebral blood flow velocities which may increase the risk of intraventricular haemorrhage. To avoid these effects, slow tracheal infusion was evaluated as a possible alternative method of surfactant administration. Saline lung lavages were performed in 13 anesthetized and artificially ventilated adult rabbits to produce respiratory distress syndrome. Curosurf (CS, 200 mg/kg) labeled with 14C-dipalmitoyl-phosphatidylcholine (-DPPC) and/or red microspheres (RMS) was instilled into the trachea either as a single bolus (n = 8) or by infusion during 45 min via a side-channel within the wall of the tracheal tube (n = 5). An arterial cannula was placed for monitoring of blood gases and BP. To determine surfactant distribution, the lungs were cut into 60-70 pieces and radioactivity and/or the number of RMS were measured in each piece. The distribution of RMS was closely related to the distribution of 14C-DPPC (r = 0.96). Bolus instillation of CS led to a prompt and sustained increase in PaO2 (from < 10.5 to > 40 kPa within 2 min), a transient decrease in BP, and a reasonably homogeneous pulmonary surfactant distribution. Tracheal infusion of CS changed neither BP nor PaO2 during the observation period of 60 min. The pulmonary distribution of CS was extremely uneven after infusion. The distribution of exogenous surfactant and its effects on gas exchange are influenced by the instillation method. An inadequate instillation technique may add to the causes of "poor response" after surfactant replacement.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8255683     DOI: 10.1203/00006450-199310000-00021

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  15 in total

Review 1.  Surfactant therapy for meconium aspiration syndrome: current status.

Authors:  Peter A Dargaville; John F Mills
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.

Authors:  H Walti; M Monset-Couchard
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

3.  Nebulisation of surfactants in an animal model of neonatal respiratory distress.

Authors:  T F Fok; M al-Essa; M Dolovich; F Rasid; H Kirpalani
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-01       Impact factor: 5.747

4.  The effects of surfactant on haemodynamics in hyaline membrane disease.

Authors:  J Skinner
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-03       Impact factor: 5.747

5.  Chest position and pulmonary deposition of surfactant in surfactant depleted rabbits.

Authors:  R Broadbent; T F Fok; M Dolovich; J Watts; G Coates; B Bowen; H Kirpalani
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-03       Impact factor: 5.747

Review 6.  [Value of surfactant replacement therapy in the treatment of acute respiratory distress syndrome].

Authors:  S Lauer; L G Fischer; H D Stubbe; H Van Aken; M Westphal
Journal:  Anaesthesist       Date:  2006-04       Impact factor: 1.041

7.  Effect of positive end-expiratory pressure on inflammatory response in oleic acid-induced lung injury and whole-lung lavage-induced lung injury.

Authors:  Koichi Nakazawa; Kuninori Yokoyama; Naoko Yamakawa; Koshi Makita
Journal:  J Anesth       Date:  2007-01-30       Impact factor: 2.078

8.  Intracerebral haemorrhages in surfactant treated neonates with severe respiratory distress syndrome: age at diagnosis, severity and risk factors.

Authors:  E Herting; O Gefeller; C P Speer; K Harms; H L Halliday; T Curstedt; B Robertson
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183

9.  Acute hemorrhagic respiratory failure caused by Wegener's granulomatosis successfully treated by bronchoalveolar lavage with diluted surfactant.

Authors:  Michael M Hermon; Johann Golej; Wolfgang Emminger; Stefan Puig; Zsolt Szepfalusi; Gerhard Trittenwein
Journal:  Wien Klin Wochenschr       Date:  2003-11-28       Impact factor: 1.704

10.  Hemodynamics of respiratory failure in rabbit model: effect of surfactant supplementation.

Authors:  M Barsotti; V Chundu; S Silvka; J Sephus; M Hallman
Journal:  Lung       Date:  1996       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.